Capital Performance Advisors LLP Procept Bio Robotics Corp Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 16 shares of PRCT stock, worth $1,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$1,556% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
267Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$471 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$339 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$149 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$121 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$115 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.34B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...